Cahaba Internal Medicine Alabaster, AL - 35007

Cahaba Internal Medicine is categorized under Internal Medicine Doctors in Alabaster, AL .

Cahaba Internal Medicine was established in 0, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Pat Phelps, Office Manager at the company’s single location by writing to 1004 1st St North # 300, Alabaster, Alabama AL 35007 or by phoning (205) 664-7970. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Cahaba Internal Medicine
Contact Person: Pat Phelps, Office Manager
Address: 1004 1st St North # 300, Alabaster, Alabama 35007
Phone Number: (205) 664-7970
Website Address: bhsala.com
Annual Revenue (USD): $500.000 to $999.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Internal Medicine Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Cahaba Internal Medicine was started in 0 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Pat Phelps, Office Manager for inquiries that concern Cahaba Internal Medicine by calling the company number (205) 664-7970, as your correspondence is most welcome. Additionally, the physical location of the single location of Cahaba Internal Medicine can be found at the coordinates 33.244583,-86.829915 as well as the street address 1004 1st St North # 300 in Alabaster, Alabama 35007.

For its online presence, you may visit Cahaba Internal Medicine’s website at bhsala.com and engage with its social media outlets through on Twitter and on Facebook.